VANCOUVER, BRITISH COLUMBIA–( EMWNews – April 8, 2008) – ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) (“ALDA”) announces that He-Yi She Ye Limited (“He-Yi”), ALDA’s agent in China has secured four contracts for the distribution of T36^® Disinfectant in China.

Evergreen Health Care has committed to minimum sales of 1 million RMB in Hong Kong and Macau for a period of one year, Jin Wei Kai Medical Technology Limited and Jin Qin Scientific Development Ltd. to 4.8 Million RMB each over three years in northern China (Beijing) and central China (Wu Hang), respectively, and Wondfo Biotech Co. Ltd. to 3 million RMB in southern China (Guang Zhou) over three years. The total sales potential of all four contracts is 13.6 Million RMB or nearly CDN $2 million at the current exchange rate.

Dr. Terrance Owen, President & CEO, states, “We are very pleased that He-Yi has already secured contracts for the distribution of ALDA’s products in China. All four companies currently market non-competing products to hospitals and medical clinics. This development provides even more incentive for He-Yi to have its manufacturing facility in operation prior to 2008 Summer Olympics in Beijing.”

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection control therapeutics derived from its patented T36^® technology. The company trades on the TSX Venture Exchange under the symbol APH.

Terrance G. Owen, Ph.D., MBA, President, CEO and Director

ALDA Pharmaceuticals Corp.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.